Curtis Wright, a former government official, played a significant role in the Food and Drug Administrations (FDA) approval of OxyContin for Purdue Pharma in 1995. After the drug's approval, Wright resigned from the FDA and took a job with the pharmaceutical company Adolor, and then later with Purdue Pharma. However, as of 2023, he is no longer employed by Purdue Pharma, which filed for Chapter 11 bankruptcy in 2019.